 is vice-president, Product Management for AI & Data at 

, based in London. A data science actuary, he has built his career in fintech and health-tech, and specializes in AI-powered, data-driven, yet human-centric product innovation. He previously led an AstraZeneca digital incubator and today remains on the board of a health charity, Scleroderma & Raynaud's UK (SRUK), which is dedicated to improving the lives of people affected by those conditions in the UK.

Articles

In a three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.

What’s Reasonable to Expect from Agentic AI in Pharma? Part One: The Evolution of AI

Videos

Advancements for novel cancer therapies are booming. This video takes a look at some of the latest efforts in the cancer research and therapy arena.

Converging Fronts of Cancer Treatments

Susan Haigney is lead editor of Pharmaceutical Technology and Pharmaceutical Technology Europe.

EMA states the new variations guidelines will streamline lifecycle management and make processing variations quicker.

European Commission Streamlines Drug Lifecyle Management

 is an expert pharmaceutical consultant based in Bengaluru, India.

While plastics have revolutionized pharmaceutical packaging, that evolution within the industry has come at a cost.

Microplastics as Vectors of Pharmaceuticals in Ecosystem: A Concern

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

In the first-ever “Two-Minute Mysteries: BioPharma Stories,” Agilent’s Ken Boda shares the mystery of a low reading.

Two-Minute Mysteries: BioPharm Stories - Episode 1: The Mysterious Cause of a Low Reading

The week's pharma news includes FDA warnings for Lilly and Novo, new drug approvals for MASH and edema, and a look ahead at CPHI Europe.

PharmTech Weekly News Roundup - Week of September 15

Feliza Mirasol is the science editor for 

CDC panel shifts vaccine policy by discouraging combined MMRV shot for young children due to increased febrile seizure risk.

CDC Panel’s Vote Separates MMRV Shot and What That Means

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

In this exclusive Drug Digest video, Steve Barr from SK pharmteco and Prasad Raje from LGM Pharma explore how supply chain pressures, sustainability, and AI adoption are reshaping small molecule development and excipient use in pharma.

Drug Digest: Small Molecules, APIs, and Excipients—Trends, Challenges, and Opportunities

Finalists for CPHI Frankfurt Pharma Awards 2025 showcase innovation in drug development, advanced manufacturing, and future industry leaders.

CPHI Frankfurt Reveals 2025 Pharma Awards Finalists for Bio/Pharma Development

The company, under parent ICE Pharma, will celebrate its past achievements, present its expertise and plans for the future, and unveil a “100 Years” logo.